Skip to main content

Thyroid Medication Recall

Westminster Pharmaceuticals, LLC recently announced a voluntary recall of the combined thyroid medication, Levothyroxine and Liothyronine (Thyroid Tablets, USP), as a precaution because they were manufactured using active pharmaceutical ingredients that were sourced prior to the FDA’s Import Alert of Sichuan Friendly Pharmaceutical Co., Ltd., which found deficiencies with Current Good Manufacturing Practices (cGMP). Substandard cGMP practices could represent the possibility of risk being introduced into the manufacturing process.

To date, Westminster Pharmaceuticals has not received any reports of adverse events related to this medication.

Because these products may be used in the treatment of serious medical conditions, patients taking the recalled medication should continue taking their medicine until they have a replacement medication.

The medication subject to recall is packed in 100-count bottles and includes the 15 mg, 30 mg, 60 mg, 90 mg and 120 mg strengths.

Westminster Pharmaceuticals is available to answer any questions regarding this recall at 1-888-354-9939, Monday through Friday, from 9 a.m. to 5 p.m., or by email at

Published on: August 29, 2018, 03:31 a.m. ET
Last updated on: April 26, 2021, 01:55 a.m. ET